Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Cited In for PubMed (Select 15753356)

1.

Proapoptotic effect of endocannabinoids in prostate cancer cells.

Orellana-Serradell O, Poblete CE, Sanchez C, Castellón EA, Gallegos I, Huidobro C, Llanos MN, Contreras HR.

Oncol Rep. 2015 Apr;33(4):1599-608. doi: 10.3892/or.2015.3746. Epub 2015 Jan 21.

2.

Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.

Schmitt J, Noble A, Otsuka M, Berry P, Maitland NJ, Rumsby MG.

Br J Cancer. 2014 Oct 14;111(8):1646-56. doi: 10.1038/bjc.2014.457. Epub 2014 Aug 19.

PMID:
25137020
3.

Cannabinoids as therapeutic agents in cancer: current status and future implications.

Chakravarti B, Ravi J, Ganju RK.

Oncotarget. 2014 Aug 15;5(15):5852-72.

4.

The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin.

Ju H, Lee S, Kang S, Kim SS, Ghil S.

Cell Commun Signal. 2014 Jul 10;12:39. doi: 10.1186/s12964-014-0039-9.

5.

Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.

Häggström J, Cipriano M, Forshell LP, Persson E, Hammarsten P, Stella N, Fowler CJ.

Prostate. 2014 Aug;74(11):1107-17. doi: 10.1002/pros.22827. Epub 2014 Jun 9.

6.

The endocannabinoid system and sex steroid hormone-dependent cancers.

Ayakannu T, Taylor AH, Marczylo TH, Willets JM, Konje JC.

Int J Endocrinol. 2013;2013:259676. doi: 10.1155/2013/259676. Epub 2013 Nov 27. Review.

7.

Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.

8.

The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.

Sreevalsan S, Safe S.

Mol Cancer Ther. 2013 Nov;12(11):2483-93. doi: 10.1158/1535-7163.MCT-13-0486. Epub 2013 Sep 12.

9.

18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.

Emonds KM, Koole M, Casteels C, Van den Bergh L, Bormans GM, Claus F, De Wever L, Lerut E, Van Poppel H, Joniau S, Dumez H, Haustermans K, Mortelmans L, Goffin K, Van Laere K, Deroose CM, Mottaghy FM.

EJNMMI Res. 2013 Aug 2;3(1):59. doi: 10.1186/2191-219X-3-59.

10.

Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.

Dando I, Donadelli M, Costanzo C, Dalla Pozza E, D'Alessandro A, Zolla L, Palmieri M.

Cell Death Dis. 2013 Jun 13;4:e664. doi: 10.1038/cddis.2013.151.

11.

Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.

Cipriano M, Häggström J, Hammarsten P, Fowler CJ.

PLoS One. 2013 Jun 5;8(6):e65798. doi: 10.1371/journal.pone.0065798. Print 2013.

12.

Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.

Van Dross R, Soliman E, Jha S, Johnson T, Mukhopadhyay S.

Life Sci. 2013 Mar 19;92(8-9):463-6. doi: 10.1016/j.lfs.2012.09.025. Epub 2012 Oct 12. Review.

13.

Towards the use of non-psychoactive cannabinoids for prostate cancer.

Pacher P.

Br J Pharmacol. 2013 Jan;168(1):76-8. doi: 10.1111/j.1476-5381.2012.02121.x.

14.

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

De Petrocellis L, Ligresti A, Schiano Moriello A, Iappelli M, Verde R, Stott CG, Cristino L, Orlando P, Di Marzo V.

Br J Pharmacol. 2013 Jan;168(1):79-102. doi: 10.1111/j.1476-5381.2012.02027.x.

15.

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.

Ramos JA, Bianco FJ.

Indian J Urol. 2012 Jan;28(1):9-14. doi: 10.4103/0970-1591.94942.

16.

Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.

Turkman N, Shavrin A, Paolillo V, Yeh HH, Flores L, Soghomonian S, Rabinovich B, Volgin A, Gelovani J, Alauddin M.

Nucl Med Biol. 2012 May;39(4):593-600. doi: 10.1016/j.nucmedbio.2011.10.019. Epub 2012 Jan 4.

17.

Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.

Sreevalsan S, Joseph S, Jutooru I, Chadalapaka G, Safe SH.

Anticancer Res. 2011 Nov;31(11):3799-807.

18.

Cannabinoids, endocannabinoids, and cancer.

Hermanson DJ, Marnett LJ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612. doi: 10.1007/s10555-011-9318-8. Review.

19.

Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

Nomura DK, Lombardi DP, Chang JW, Niessen S, Ward AM, Long JZ, Hoover HH, Cravatt BF.

Chem Biol. 2011 Jul 29;18(7):846-56. doi: 10.1016/j.chembiol.2011.05.009.

20.

The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.

Miller LK, Devi LA.

Pharmacol Rev. 2011 Sep;63(3):461-70. doi: 10.1124/pr.110.003491. Epub 2011 Jul 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk